DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
New, More Accessible Staging System Developed to Predict Survival for Patients With Light Chain Amyloidosis
A new staging system developed with a more accessible test to predict the chance of survival in patients living with light chain (AL) amyloidosis. Led by researchers from the Amyloidosis Center at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), the test incorporates cardiac biomarkers to accurately identify the involvement of the heart in the disease, allowing doctors to predict outcomes of patients with AL amyloidosis.
AL Amyloidosis is a rare condition caused when bone marrow produces abnormal antibodies that can’t be broken down and are deposited in tissues, interfering with organ function. Survival for patients with AL amyloidosis is related to cardiac involvement, making cardiac biomarkers an accurate measure for staging for risk stratification.
Source: www.bumc.bu.edu
Share
myBinder
Related Content
-
educationCan I Exercise if I Have AL Amyloidosis?It is believed that exercise is benefici...
-
educationWhat is New in Diagnosis and Management of Light Chain Amyloidosis?Light chain (AL) amyloidosis is caused b...
-
videos & visualsFollowup Questions on CAEL101: Michael Spector – ASG Webinar 8/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
educationSteroids for AL AmyloidosisSteroids are drugs which mimic certain h...
-
videos & visualsClarification on Prothena AFFIRM and CAEL-101 Global Trials: Muriel Finkel – ASG Webinar 11/13https://www.youtube.com/watch?v=NrEjyVeJ...
-
people & placesMarina Ramirez-Alvarado, PhDMarina Ramirez-Alvarado is a Professor o...
-
videos & visualsMessage to Physicians From Cardiac Amyloidosis Patienthttps://www.youtube.com/watch?v=C2xv62cI...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.